Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001636178-25-000004

CFO AND TREASURER sold 21,000 shares at an average $436.09 ($9,157,821)

  • CFO AND TREASURER acquired 21,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-04 Exercise or conversion : show line 1 in the form 10b5-1 +21,000 $146.03 $3,066,630 29,118 D
2025-11-04 Sale : show line 2 in the form 10b5-1 −98 $432.09 $42,345 29,020 D
2025-11-04 Sale : show line 3 in the form 10b5-1 −1,074 $432.86 $464,892 27,946 D
2025-11-04 Sale : show line 4 in the form 10b5-1 −1,512 $433.78 $655,872 26,434 D
2025-11-04 Sale : show line 5 in the form 10b5-1 −1,679 $434.96 $730,302 24,755 D
2025-11-04 Sale : show line 6 in the form 10b5-1 −6,088 $435.81 $2,653,239 18,667 D
2025-11-04 Sale : show line 7 in the form 10b5-1 −7,317 $436.78 $3,195,910 11,350 D
2025-11-04 Sale : show line 8 in the form 10b5-1 −2,752 $437.74 $1,204,662 8,598 D
2025-11-04 Sale : show line 9 in the form 10b5-1 −360 $438.50 $157,859 8,238 D
2025-11-04 Sale : show line 10 in the form 10b5-1 −120 $439.51 $52,741 8,118 D
Open-market sales · 21,000 sh · avg $436.09 · $9,157,821

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-11-04 Exercise or conversion : show line 11 in the form 10b5-1 Stock Options −21,000 $146.03 2027-03-15 21,000 31,312 D
Loading xslF345X05/primarydocument.xml…